English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Methods Clinical data and DCMR results were analyzed in 1466 consecutive patients undergoing DCMR between 2000 and 2004. Ninety four patients lost to follow-up and three hundred fifty five patients who underwent early revascularization within 3 months of DCMR were excluded from analysis. The remaining 1017 patients (median age, 62 years) were followed up for a mean of 44 ± 24 months (range: 1 to 116 months). Wall motion abnormalities (WMA) at rest and the presence of stress-induced WMA (ischemia) were assessed for each patient. Cardiac events, defined as cardiac death and non-fatal myocardial infarction, were related to clinical and DCMR results. Patients with inducible WMA were compared in regards to following therapy (revascularization or medical therapy alone) and outcome.

Long-term prognostic value of dobutamine cardiovascular magnetic resonance in 1466 patients and its value for clinical decision making